Jiahuan Lu

1.0k total citations
21 papers, 304 citations indexed

About

Jiahuan Lu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiahuan Lu has authored 21 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Jiahuan Lu's work include Liver physiology and pathology (3 papers), Cancer Cells and Metastasis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Jiahuan Lu is often cited by papers focused on Liver physiology and pathology (3 papers), Cancer Cells and Metastasis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Jiahuan Lu collaborates with scholars based in China, Hong Kong and South Korea. Jiahuan Lu's co-authors include Kai Sheng, Huijun Zhao, Hui Zhao, Zhao-Lei Zeng, Zhifeng Shi, Hui Xu, Feng Wang, Huai‐Qiang Ju, Qi‐Nian Wu and Zhan‐Hong Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Jiahuan Lu

21 papers receiving 301 citations

Peers

Jiahuan Lu
Sangyun Shin South Korea
Amanda B. Parris United States
Mihir B. Doshi United States
Sangyun Shin South Korea
Jiahuan Lu
Citations per year, relative to Jiahuan Lu Jiahuan Lu (= 1×) peers Sangyun Shin

Countries citing papers authored by Jiahuan Lu

Since Specialization
Citations

This map shows the geographic impact of Jiahuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiahuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiahuan Lu more than expected).

Fields of papers citing papers by Jiahuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiahuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiahuan Lu. The network helps show where Jiahuan Lu may publish in the future.

Co-authorship network of co-authors of Jiahuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiahuan Lu. A scholar is included among the top collaborators of Jiahuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiahuan Lu. Jiahuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Yonglun, Ming Yue, Chunhua Xu, et al.. (2025). RGMb drives macrophage infiltration to aggravate kidney disease. Proceedings of the National Academy of Sciences. 122(11). e2418739122–e2418739122. 1 indexed citations
2.
Jia, Rongrong, et al.. (2024). TGF - β/SMAD signaling pathway and protein molecules in the treatment of liver fibrosis: A natural lipid membrane protein of exosomes. International Journal of Biological Macromolecules. 280(Pt 1). 135654–135654. 3 indexed citations
3.
Sun, Yuhan, Jiahuan Lu, Jing Wu, et al.. (2024). Potential mechanism of CARD16 protein action and susceptibility to sepsis in the elderly infected population: Through transcriptome analysis of blood. International Journal of Biological Macromolecules. 281(Pt 4). 136578–136578. 1 indexed citations
4.
Sun, Yuhan, Hua Wang, Haocheng Zhang, et al.. (2024). Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism. International Journal of Biological Macromolecules. 281(Pt 2). 136183–136183. 1 indexed citations
5.
Zhang, Ying, Jiahuan Lu, Ji‐Yu Wang, et al.. (2024). The influence of biophysical niche on tumor-associated macrophages in liver cancer. Hepatology Communications. 8(11). 3 indexed citations
6.
Li, Chenglin, et al.. (2024). Lightweight Network of Multi-Stage Strawberry Detection Based on Improved YOLOv7-Tiny. Agriculture. 14(7). 1132–1132. 1 indexed citations
7.
Zhang, Yixuan, Jintian Chen, Huanyu Wang, et al.. (2024). Abstract 5520: β2 adrenergic receptor signaling promotes colorectal cancer liver metastasis. Cancer Research. 84(6_Supplement). 5520–5520. 1 indexed citations
8.
Li, Jinwei, et al.. (2024). Cinobufagin disrupts the stability of lipid rafts by inhibiting the expression of caveolin-1 to promote non-small cell lung cancer cell apoptosis. Archives of Medical Science. 20(3). 887–908. 3 indexed citations
9.
Qiang, Huiping, Yinchen Shen, Jiaqi Li, et al.. (2022). Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study. Translational Lung Cancer Research. 11(1). 87–99. 18 indexed citations
10.
Chang, Qing, Huiping Qiang, Jialin Qian, et al.. (2021). Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study. Frontiers in Oncology. 11. 652560–652560. 12 indexed citations
11.
Wang, Yun, Jiahuan Lu, Feng Wang, et al.. (2020). Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Cancer Letters. 473. 74–89. 79 indexed citations
12.
Zeng, Zhao-Lei, Jiahuan Lu, Qi Zhao, Yun Wang, & Qi‐Nian Wu. (2020). IDDF2020-ABS-0177 ERBB4 high expression and mutations in gastric cancer present opportunities for clinical landscape and therapeutic development. Abstracts. A22.1–A22. 1 indexed citations
14.
Lu, Jiahuan, Yun Wang, Qi Meng, & Zhao-Lei Zeng. (2019). Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines. Journal of Visualized Experiments. 5 indexed citations
15.
Chen, Zhan‐Hong, Jingjing Qi, Qi‐Nian Wu, et al.. (2019). Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 196–196. 38 indexed citations
16.
Sheng, Kai, Jiahuan Lu, & Huijun Zhao. (2018). ELK1-induced upregulation of lncRNA HOXA10-AS promotes lung adenocarcinoma progression by increasing Wnt/β-catenin signaling. Biochemical and Biophysical Research Communications. 501(3). 612–618. 43 indexed citations
17.
Chen, Zhan‐Hong, Qi‐Nian Wu, Jiahuan Lu, et al.. (2018). Eukaryotic initiation factor 4A2 (EIF4A2) expression in colorectal cancer and prediction of prognosis.. Journal of Clinical Oncology. 36(4_suppl). 664–664. 1 indexed citations
18.
Sheng, Kai & Jiahuan Lu. (2016). Typical airborne quinones modulate oxidative stress and cytokine expression in lung epithelial A549 cells. Journal of Environmental Science and Health Part A. 52(2). 127–134. 13 indexed citations
19.
Sheng, Kai, et al.. (2014). Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent. Biochemical and Biophysical Research Communications. 452(3). 768–774. 52 indexed citations
20.
Lu, Jiahuan, Zhifeng Shi, & Hui Xu. (2013). The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells. Molecular and Cellular Biochemistry. 389(1-2). 17–24. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026